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Abstract: 
The role of the TPR2B domain of Hop is as yet unknown. We have shown here by site 
directed mutagenesis and size exclusion chromatography for the first time that the TPR1 and 
TPR2B domains of Hop independently dimerized, and that the dimerization of TPR2B was 
not dependent on its predicted two-carboxylate clamp residues. Furthermore, our data 
indicated that the dimerization of Hop and its domains was not disrupted in the presence of 
Hsp70 and Hsp90 peptides. 
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INTRODUCTION 
 
The tetratricopeptide repeat (TPR) is a degenerate 34-amino acid repeat motif found in many 
proteins of diverse function and is believed to mediate protein-protein interactions. A TPR 
domain may contain from three to more than 16 TPR repeats [1], each TPR repeat making up 
a helix-turn-helix motif, tandem repetition of which ultimately forms a TPR domain with a 
superhelical groove structure [2]. Isolated TPR domains exhibit similar structural and binding 
characteristics to TPR domains in the context of the full-length protein: the affinity of isolated 
TPR domains for their peptide ligands is not significantly different to that of the full-length 
protein [3, 4, 5]; and ligand-bound TPR structure [2, 6, 7, 8] is not significantly different to 
that of ligand-free TPR structure [3, 9]. It is therefore clear that a TPR is folded to start with 
and remains folded upon peptide ligand binding, folding cooperatively as a structurally 
independent unit [9]. 
 
The structures of the TPR domains of Hsp70/Hsp90 Organising Protein (Hop) have been well 
characterised [3]. Hop contains nine TPR motifs that are clustered into three TPR domains, 
TPR1, TPR2A and TPR2B [10]. TPR1 and TPR2A of Hop are able to bind simultaneously to 
the EEVD motifs of Hsp70 and Hsp90 respectively [3, 11], facilitating Hop’s function as a 
scaffold protein in the formation of the Hsp70/Hop/Hsp90 chaperone heterocomplex [3, 12, 
13]. Hop further contains two small domains containing aspartic acid-proline (DP) repeat 
motifs: DP1 and DP2 arranged as TPR1-DP1-TPR2A-TPR2B-DP2 [14]. 
 
However, despite the wealth of TPR tertiary structure data available, reports on the quaternary 
structure or oligomeric state of TPR-containing proteins, and the role of the TPR motif in 
oligomerization are limited and contradictory. Intermolecular TPR interactions resulting in 
self-associations have been noted, although the relevance and details of such self-associations 
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to the solution properties of TPR-containing proteins remains unclear [1, 15, 16]. While the 
TPR-containing PP5 formed a dimer when crystallized [2], it was shown, by analytical gel 
filtration chromatography, to be a monomer in solution [15]. Similarly, intermolecular 
interactions have been observed for both monoclinic and tetragonal crystal forms of TPR-
containing cyclophilin 40 [6], while in solution it was found to be monomeric and to resemble 
the monoclinic crystal form [17]. A small TPR-containing eukaryotic protein involved in 
disease resistance, small glutamine-rich protein, Sgt1, from Arabidopsis thaliana, barley and 
yeast reversibly self-associates in vitro in a concentration dependent manner while human 
Sgt1 does not [18]. It has been proposed that this self-association property of Sgt1 is mediated 
by its TPR domain, the degree of self-association being sequence- and therefore species-
dependent [18]. Furthermore, TPR residues thought to be involved in the self-association of 
TPR-containing Sgt1, have been mapped to certain highly charged (R/K/E) terminal residues 
[18]. 
 
Hop has been found to exist as a dimer [17, 19, 20, 21, 22] and as a monomer [21, 23]. It has 
been proposed that full-length Hop exists in solution in equilibrium between a monomeric and 
dimeric state, associating with Hsp90 in a dimer-dimer interaction [20] and with Hsp70 in a 
monomer-monomer interaction [20, 21]. Furthermore, it has been hypothesized that cytosolic 
Hop may be regulated between monomeric and dimeric states, thereby facilitating its adaptor 
function within the chaperone heterocomplex machinery. There are also contrasting reports on 
the oligomeric state of the isolated TPR domains of Hop. The Hop TPR1 domain has been 
reported to be a monomer in solution [16, 17], as has the Hop TPR2A domain [16]. However, 
the TPR1 and TPR2A each crystallized as dimers [3], and TPR2A has been reported to be 
both necessary and sufficient for Hop to dimerize [17, 24].  
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There is limited data regarding the function of TPR2B in Hop. However, it has been 
suggested that TPR2B plays a role in dimerization [17], that it may be required for Hsp70 
binding [22, 24, 25], and that it has Hsp90-binding capacity [10, 24, 26]. The DP2 region in 
mammalian Hop, C-terminal of the TPR2B domain, has been proposed to be important for 
Hsp70 binding [10, 27], and/or Hsp90 binding [28], and to be involved in the maturation of 
the steroid receptor [27, 28]. However the DP2 region in yeast Hop has been shown to be 
dispensable for Hsp70 and Hsp90 interaction as well as yeast Hop dimerization [24]. Residues 
in both TPR1 and TPR2B-DP2 have been identified as co-evolving with Hsp70, whereas 
residues in TPR1, TPR2A, and TPR2B have been identified as co-evolving with Hsp90 [29]. 
In light of recent reports [17] that show conclusively that TPR2A is involved in the 
dimerization of Hop, we did not focus our dimerization studies on TPR2A, but rather on 
TPR2B. Therefore, this study involves an assessment of the contribution of the TPR2B 
domain to the dimerization of Hop. 
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MATERIALS AND METHODS 
 
General procedures 
Standard techniques including agarose gel electrophoresis, competent bacterial cell 
preparation, purification of plasmid DNA, polymerase chain reaction (PCR), ligation 
reactions, restriction enzyme digestion, sodium-dodecyl-sulfate/polyacrylamide gel 
electrophoresis (SDS-PAGE) [30], and Western blotting [31] were carried out according to 
common protocols [32].  
 
Materials 
GoTaq® DNA polymerase, dNTPs, pGEM(T) Easy Vector System I, and Pfu DNA 
polymerase were from Promega (Madison, WI, USA). Primers were from Integrated DNA 
Technologies (Coralville, IA, USA). pQE30 was from Qiagen GmbH (Hilden, Germany). 
Anti-mouse secondary antibody, Superdex ® column, and SepharoseTM Fast Flow were from 
Amersham Biosciences (Piscataway, NJ, USA). Sephadex G-25 was from Sigma (St. Louis, 
MO, USA). Hsp70 and Hsp90 peptide was from GenScript Corporation. (Piscataway, NJ, 
USA). Hsp70 was a gift from David Toft. 
 
Plasmids and plasmid construction 
The cloning of bacterial construct pQE302000 is described elsewhere [20]. pQE302000 
encodes full-length mouse Hop with an amino-terminal His-tag. To produce pQE301000, Hop 
cDNA encoding amino acids 365-543 (Hop 365-543) was PCR amplified from template 
pQE302000 using primers F-BamHI-TPR2B (att agg atc ccg ctt ggc tta tat caa c) and R-PstI-
TPR2B (att act gca gtc acc gaa ttg cga tc), which included a BamHI and a PstI site 
respectively. The PCR product was subcloned into pGEM(T) Easy Vector System I and the 
Hop 365-543 fragment cloned into pQE30 BamHI/PstI sites using standard cloning 
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techniques. pQE301000 encoded a His-tagged Hop truncation including the TPR2B and the 
DP2 domains and was called His-TPR2B-DP2. 
 
To produce pQE30TPR1, Hop cDNA encoding amino acids 1- 219 (Hop 1-219) was PCR 
amplified from template pQE302000 using primers F-PCR-fwd (att gca tgc atg gag cag gtg 
aat g) and R-PstI-TPR1 (att act gca gtc att ctt cca ttg gtt ctg g), which included a SphI and a 
PstI site respectively. The PCR product was subcloned into pGEM(T) Easy Vector System I 
and the Hop 1-219 fragment cloned into pQE30 SphI/PstI sites using standard cloning 
techniques. pQE30TPR1 encoded a His-tagged Hop truncation including the TPR1and the 
DP1 domains and was called His-TPR1-DP1. 
 
Site-directed mutagenesis 
pQE302000 (K364A; N368A) and pQE302000 (K429A; R433A), were generated to encode 
full-length His-Hop 1-543 with double alanine substitutions at positions 364 and 368, and at 
429 and 433 respectively. Similarly, pQE301000 (K364A; N368A) and pQE301000 (K429A; 
R433A) were generated to encode His-Hop 365-543 with double alanine substitutions at 
positions 364 and 368, and at 429 and 433 respectively. Site-directed mutagenesis reactions 
were carried out using the templates pQE302000 or pQE301000 in a linear amplification 
reaction using mutagenic primers F-Hop-K364A,N368A (ctt ggc ttt gga gga agc taa caa ggg 
cgc cga atg ctt cca gaa ag); R-Hop-K364A,N368A (ctt tct gga agc att cgg cgc cct tgt tag ctt 
cct cca aag cca ag) and F-Hop-K429A,R433A (gag cca acc ttc atc gct ggg tat act gca aaa gca 
gct gct ctg) and R-Hop-K429A,R433A (cag agc agc tgc ttt tgc agt ata ccc agc gat gaa ggt tgg 
ctc).  
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His-Hop purification and SE-FPLC 
For purification of His-tagged Hop proteins by immobilized metal chelate affinity 
chromatography, a soluble cell extract was prepared from induced E. coli XL1Blue cells 
carrying one of the pQE30 derived plasmids sonicated in start buffer (50 mM sodium 
phosphate buffer, (pH 7.5), 300 mM NaCl, 20 mM imidazole, 1 mM PMSF). The soluble cell 
extract from a 500 ml culture was incubated with 500 µl 50% (w/v) slurry of SepharoseTM 
Fast Flow (1 ml bed volume per 1 l of culture) previously equilibrated with start buffer, with 
gentle agitation, for 30 min at room temperature. Thereafter, the His-Hop saturated beads 
were washed extensively with ice-cold wash buffer (50 mM sodium phosphate buffer, (pH 
7.5), 300mM NaCl, 80 mM imidazole, 1 mM PMSF) before elution with 500 µl elution buffer 
(50 mM sodium phosphate buffer, (pH 7.5), 300 mM NaCl, 300 mM imidazole, 1 mM 
PMSF). The eluant (500 µl) was buffer exchanged on a 15 ml Sephadex G-25 column into 
FPLC buffer (50 mM Tris, pH 7.5, 150 mM NaCl), and the concentration of protein eluted 
quantified using the Bradford method [33]. The buffer exchange was also an important step 
for the removal of divalent metal ions and imidazole that may confound with the subsequent 
oligomerization studies. The relative molecular masses of His-Hop truncation and site 
directed derivatives were determined using size-exclusion gel fast performance liquid 
chromatography (FPLC). Samples (100 µl) were loaded onto a 30 cm Superdex® column 
equilibrated with filtered degassed FPLC buffer (50 mM Tris, pH 7.5, 150 mM NaCl). 
Typically, a range of 20-200 µM His-Hop proteins and its derivatives were resolved, with 
equal concentrations of Hop and its derivatives used in any particular experiment. Aldolase 
(158 kDa), ovalbumin (45 kDa), BSA (66.2 kDa), lysozyme (14.4 kDa) were used as 
molecular size references. The experimentally derived relative molecular masses were divided 
by the predicted molecular mass (calculated using standard software packages) to obtain the 
stoichiometry ratio. 1 ml fractions collected were precipitated by the addition of 5 ml acetone 
(-20°C) followed by incubation at -20°C overnight. Precipitated protein was collected by 
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centrifugation at 13 000 rpm in a desktop centrifuge, resuspended in PBS, and resolved by 
SDS PAGE.  
 
Peptide ligand binding assays 
Peptide ligand binding assays included 20-200 µM His-Hop or derivatives and 26-260 µM 
peptide in a final volume of 100 µl. Hsp70 peptide (GSGPTIEEVD) and Hsp90 peptide 
(DDTSRMEEVD) were suspended in DMSO according to manufacturer’s instructions, added 
to the binding assays in a ratio of 1:1.3 [3], and the binding assays incubated overnight on ice 
with gentle agitation. The assays were then resolved by SE-FPLC and fractions collected were 
analyzed by SDS PAGE as described above. 
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RESULTS AND DISCUSSION 
 
Two-carboxylate clamp residues were conserved in TPR1, TPR2A and TPR2B domains 
of Hop 
A sequence alignment of TPR1, TPR2A, and TPR2B domains of Hop [25], predicts K364 and 
N368 in TPR2B to be topologically equivalent to the two-carboxylate clamp residues K8 and 
N12 in TPR1, and predicts K429 and R433 in TPR2B to be topologically equivalent to the two-
carboxylate clamp residues K73 and R77 in TPR1, as shown in Figure (1A). Figure (1B) shows 
the various His-Hop protein derivatives used in this study. We performed charged-to-alanine 
scanning mutagenesis of the predicted two-carboxylate clamp residues in TPR2B, generating 
double mutations in the full length Hop and the truncated TPR2B proteins: His-Hop (K364A; 
N368A), His-Hop (K429A; R433A), His-TPR2B (K364A; N368A), and His-TPR2B (K429A; 
R433A).  
 
His-Hop and His-TPR1-DP1 elute as both monomeric and dimeric species but His-
TPR2B-DP2 elutes only as a dimeric species 
The SE-FPLC analysis of the dimerization of His-Hop and its derivatives is shown in Table 
(1), and revealed that His-Hop eluted as both a monomer (68.6 kDa) and a dimer (106.3 kDa), 
consistent with previous reports [19, 20, 21]. The possibility existed that Hop migrated as an 
extended monomer configuration rather than a dimer with a globular configuration. However, 
in light of our previous glutaraldehyde cross-linking studies [21], we believe that Hop 
dimerizes in a protein concentration-dependent manner. In this study we did not specifically 
test the concentration dependence of the dimerization, and the relatively high protein 
concentrations required for the SEC-FPLC analysis would have favoured dimerization. 
Interestingly, mutation of the predicted two-carboxylate clamp residues of TPR2B in the full-
length protein eliminated the monomer peak, so that only dimers of His-Hop (K364A; 
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N368A) and His-Hop (K429A; R433A) were detected. We therefore conclude that the 
predicted two-carboxylate clamps of TPR2B, although not necessary for dimerization of Hop 
to occur, may increase stability of the protein when in the monomeric state.  
 
Interestingly, as shown in Table (1) the SE-FPLC analysis revealed that His-TPR1-DP1 
eluted as two species, a monomer potentially in an extended conformation (34.2 kDa) and a 
dimer (55.2 kDa), suggesting that TPR1-DP1 may be involved in the dimerization of Hop.  In 
addition, His-TPR2B-DP2 eluted as a dimer (39.3 kDa), the formation of which was not 
affected by mutation of the predicted two-carboxylate clamp residues. Our results are 
therefore not consistent with previous findings reporting both isolated mammalian Hop TPR1 
residues 1-115 and yeast Hop TPR2B residues 388-519 as monomers [16, 24]. Mutations in 
the C-terminal DP (DP2) motif have been reported to disrupt interaction with Hsp70 possibly 
by disruption of interdomain interactions [10] or structural integrity [34], although this 
disruption was also not observed by other groups [28]. 
 
Furthermore, although TPR2A has been found to be both necessary and sufficient for purified 
yeast Hop to migrate as a dimer in solution [17, 28], our results indicate that dimerization of 
mammalian Hop may also involve the TPR1-DP1 and TPR2B-DP2 domains. When His-
TPR1-DP1 and His-TPR2B-DP2 were incubated together and subsequently resolved by SE-
FPLC, in combination we observed similar peaks to those obtained for the independently 
resolved His-TPR1-DP1 and His-TPR2B-DP2 indicating that TPR1-DP1 and TPR2B-DP2 
probably do not exhibit inter-domain interactions with one another (data not shown). The DP-
repeat region of Hop has been thought to influence the folding of the other Hop domains, and 
it has been proposed that the DP2 acts as a structural element within the C-terminal domain 
which is important for Hop function [34]. We did not observe elution of a single species of 
His-TPR1-DP1-His-TPR2B-DP2 suggesting that if direct, intramolecular interaction between 
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the Hop DP domain and the TPR1 domain is required for maximal Hsp70 binding, this may 
only occur in the full-length protein.  
 
His-Hop, His-TPR1-DP1, and His-TPR2B-DP2 dimerize in both the presence and 
absence of peptide ligands 
His-Hop, His-TPR1-DP1, and His-TPR2B-DP2 were incubated with Hsp70 and Hsp90 
peptide ligands and then resolved by SE-FPLC as before. Proteins eluting from the SE-FPLC 
column were collected as fractions, precipitated and resolved by SDS PAGE. We found that 
incubation of His-Hop and derivatives with Hsp70 and Hsp90 peptide ligands did not affect 
dimerization, as shown in Figure (2). We did notice, however, that incubation of the peptides 
with His-TPR2B-DP2 decreased the apparent size of the dimer peak, but we did not regard 
this reduction as significant. It is possible that the peptides had too low an affinity or were 
aggregated thereby limiting their interaction with Hop and its derivatives. Alternatively, more 
extensive C-terminal peptide regions of Hsp70 and Hsp90 may be required before an effect on 
Hop oligomerization is observed. 
 
CONCLUSION 
In light of the importance of TPR domains in inter-protein associations, the potential for TPR 
domains to interact with one another would have important regulatory consequences. Here we 
provide evidence that both TPR1-DP1 and TPR2B-DP2 independently dimerize, and are 
therefore potentially involved in the dimerization of the full length Hop protein. Furthermore, 
this dimerization does not appear to be affected by peptide ligand binding and is not 
dependent on predicted two-carboxylate clamp residues within TPR2B. Dimerization and 
Hsp70/Hsp90 binding may therefore be cooperative rather than competitive processes.  
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ABBREVIATIONS 
TPR   =  Tetratricopeptide Repeat Domain 
Hsp70   =  Heat Shock Protein 70 
Hsp90   =  Heat Shock Protein 90 
Hop  = Hsp70/Hsp90 Organising Protein 
PP5   =  Protein Phosphatase Type 5 
PCR  = Polymerase Chain Reaction 
SDS-PAGE = Sodium-Dodecyl-Sulfate/Polyacrylamide Gel Electrophoresis 
dNTP   =  DeoxyribonucleotideTriphosphate 
SE-FPLC = Size Exclusion Fast Protein Liquid Chromatography 
FPLC  = Fast Protein Liquid Chromatography 
SE-FPLC = Size Exclusion Fast Protein Liquid Chromatography 
PMSF  = Phenylmethanesulphonylfluoride 
DMSO  = Dimethyl sulfoxide 
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TABLE 
 
Table 1: SE-FPLCa of His-Hop, His-TPR1-DP1, and His-TPR2B-DP2 
Protein Amino acids 
included 
Experimental 
Mr 
Predicted Mr 
of monomer 
Apparent 
Stoichiometry 
His- Hop 1-543 106.3 kDa 
68.6 kDa 
60.6 kDa dimer (1.8) 
monomer (1.1) 
His-Hop (K364A, N368A) 1-543 101.2 kDa 60.6 kDa dimer (1.7) 
His-Hop (K429A, R433A) 1-543 103.2 kDa 60.6 kDa dimer (1.7) 
His-TPR1 1-216 55.2 kDa 
34.2 kDa 
25.0 kDa dimer (2.2) 
monomer (1.4) 
His-TPR2B  365-543 39. 3 kDa 22.3 kDa dimer (1.8) 
His-TPR2B (K364A, 
N368A) 
365-543 39. 9 kDa 22.3 kDa dimer (1.8) 
HisTPR2B (K429A, 
R433A) 
365-543 39.9 kDa 22.3 kDa dimer (1.8) 
aThe relative molecular mass (Mr) of His-Hop and derivatives was determined using Size-Exclusion Fast Protein 
Liquid Chromatography (SE-FPLC). His-Hop and its derivatives (20-200 µM in 100 µl) were loaded onto a 30 
cm Superdex® column equilibrated with filtered degassed FPLC buffer. Aldolase (158 kDa), ovalbumin (45 
kDa), BSA (66.2 kDa), lysozyme (14.4 kDa) were used as globular protein molecular mass markers. The 
experimentally derived relative molecular masses were divided by the predicted molecular mass of the monomer, 
as calculated using standard software packages, to obtain the apparent stoichiometry ratio. 
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FIGURE LEGENDS 
 
Figure 1: TPR domain organization in mSTI1 and multiple sequence alignment of TPR 
domains from Hsp70-interacting proteins.  
A: Alignment of TPR1, TPR2A, and TPR2B domains of Hop was according to Odunuga et 
al., 2003 [34]: TPR1, N-terminal TPR domain of Hop; TPR2A, first central TPR domain of 
Hop; and TPR2B, second central TPR domain of Hop. The conserved two-carboxylate clamp 
residues in TPR1 and TPR2A, and the predicted two-carboxylate clamp residues in TPR2B 
are shown against a black background. The residues involved in the A and B helices of the 
respective TPRs are indicted at the top. 
B: Schematic representation of His-Hop derivatives showing the His tag (large solid bars), 
Hop sequence (large open bars), TPR motifs (small open bars), and TPR domains (as 
indicated on grid). The numbering refers to amino acid positions in Hop.  
 
Figure 2: Hop, TPR1, and TPR2B dimerize in the presence of Hsp70 and Hsp90 peptide 
ligands 
Peptide ligand binding assays containing 20-200 µM His-Hop or derivatives and 26-260 µM 
Hsp70 peptide (GSGPTIEEVD) or Hsp90 peptide (DDTSRMEEVD) in a final volume of 
100 µl were incubated overnight on ice and resolved by SE-FPLC as described for Table 1. 
Fractions collected were acetone precipitated and analyzed by SDS PAGE. Top panel: His-
Hop, middle panel: His-TPR1, and lower panel: His-TPR2B show SE-FPLC traces of His-
tagged proteins with no peptide (solid thick line), in the presence of Hsp70 peptide (dashed 
line), and in the presence of Hsp90 peptide (dotted line). The precipitated proteins as resolved 
by SDS PAGE are shown in the inserted panels below the SE-FPLC fractions from which 
they were obtained. 
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TPR1     4   VNELKEKGNKALSAGNIDDALQCYSEAIKLDPQNHVLYSNRSAAYAKKGDYQKAYEDGCKTVDL----KPDWG---KGYSRKAAALEFLNRFEEAKRTYEEGL-KHEAN---- 104 
TRP2A  225   ALKEKELGNDAYKKKDFDKALKHYDRAKELDPTNMTYITNQAAVHFEKGDYNKCRELCEKAIEVGRENREDYRQIAKAYARIGNSYFKEEKYKDAIHFYNKSLAEHRTP---- 333 
TPR2B  360   ALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPRDAKLYSNRAACYTKLLEFQLALKDCEECIQL----EPTFI---KGYTRKAAALEAMKDYTKAMDVYQKALDLDSSC---- 461 
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